新华医疗：关于控股股东增持公司股份进展公告

Core Viewpoint - The announcement from Xinhua Medical indicates a strong confidence from its controlling shareholder in the company's future development and long-term investment value, as evidenced by the planned share buyback program [2] Group 1: Shareholder Actions - The controlling shareholder, Shandong Yiyang Health Industry Development Group, plans to increase its stake in Xinhua Medical by purchasing between RMB 100 million and RMB 200 million worth of A-shares over the next 12 months [2] - As of the announcement date, Shandong Health Group has already acquired 3,863,800 shares, representing approximately 0.6369% of the total share capital, exceeding 50% of the lower limit of the planned buyback amount [2] - The share buyback will be executed through the Shanghai Stock Exchange's trading system without triggering a mandatory bid or changing the control of the company [2]